HealthEquity Sees FY24 Adj. EPS $2.08-$2.16 vs $2.02 Est., Revenue $985M-$995M vs $989M Est.
Portfolio Pulse from Benzinga Newsdesk
HealthEquity projects FY24 adjusted EPS to be between $2.08 and $2.16, surpassing the estimated $2.02. The company also forecasts revenue to range from $985M to $995M, which brackets the estimated $989M.
December 05, 2023 | 9:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HealthEquity anticipates higher-than-expected adjusted EPS for FY24 and provides revenue guidance that encompasses the consensus estimate.
HealthEquity's projection of a higher adjusted EPS than analysts' estimates is a positive signal for investors, suggesting the company's performance may exceed market expectations. The revenue guidance, which is in line with estimates, further supports the positive outlook. This news is likely to instill investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100